Company news
Achieve Life Sciences, Inc. news in 2023
Achieve Life Sciences, Inc.'s news releases, calls and decks from 2023, newest first.
Achieve Life Sciences Reports Financial Results for Third Quarter and Provides Corporate Update
November 8, 2023
Achieve Life Sciences to Announce Third Quarter 2023 Financial Results and Host Conference Call and Webcast on November 9, 2023
October 25, 2023
Achieve Life Sciences Announces Presentation of Cytisinicline E-Cigarette Cessation (ORCA-V1) Results at Society for Research on Nicotine and Tobacco Europe (SRNT-E) Annual Meeting
September 10, 2023
Achieve Life Sciences Reports Financial Results for Second Quarter 2023 and Provides Corporate Update
August 13, 2023
Achieve Life Sciences to Announce Second Quarter 2023 Financial Results and Host Conference Call and Webcast
July 31, 2023
Achieve Life Sciences Announces Presentation at 2023 American Society of Pharmacognosy Annual Meeting
July 17, 2023
Achieve Life Sciences Announces Publication of Cytisinicline Phase 3 ORCA-2 Smoking Cessation Trial in Journal of the American Medical Association (JAMA)
July 10, 2023
Achieve Life Sciences Announces Pricing of $16.5 Million Registered Direct Offering
May 24, 2023
Achieve Life Sciences Reports Statistically Significant Smoking Cessation Benefit for Cytisinicline in Second, Confirmatory Phase 3 Clinical Trial
May 22, 2023
Achieve Life Sciences Announces Refinancing of Outstanding Loan with Silicon Valley Bank
May 16, 2023
Achieve Life Sciences Reports Financial Results for First Quarter 2023 and Provides Corporate Update
May 8, 2023
Achieve Life Sciences to Announce First Quarter 2023 Financial Results and Host Conference Call and Webcast on May 9, 2023
April 25, 2023
Achieve Life Sciences Announces Positive Phase 2 ORCA-V1 Trial Results Showing Statistically Significant Vaping Cessation Benefit for Participants Treated with Cytisinicline
April 19, 2023
Achieve Life Sciences to Present at Life Science Innovation Northwest 2023 Conference
April 13, 2023
Achieve Life Sciences Announces Refresh to Board of Directors
March 29, 2023
Achieve Life Sciences Announces Last Subject Last Visit Completed in Phase 3 ORCA-3 Trial of Cytisinicline for Smoking Cessation
March 28, 2023
Achieve Life Sciences Announces Granting of New Hire Inducement Award
March 16, 2023
Achieve Life Sciences Reports Financial Results for Fourth Quarter and Year-End 2022 and Provides Corporate Update
March 15, 2023
Achieve Life Sciences Announces Last Subject Last Visit Completed in Phase 2 ORCA-V1 Trial of Cytisinicline for e-Cigarette Cessation
March 7, 2023
Achieve Life Sciences Announces Presentation of the Phase 3 ORCA-2 Trial of Cytisinicline at Society for Research on Nicotine and Tobacco (SRNT) Annual Meeting
March 2, 2023
Achieve Life Sciences to Announce Fourth Quarter and Year-End 2022 Financial Results and Host Conference Call and Webcast on March 16, 2023
March 1, 2023
Achieve Life Sciences Announces Last Subject Dosed in Phase 2 ORCA-V1 Trial of Cytisinicline for e-Cigarette Cessation
February 6, 2023
Achieve Life Sciences to Participate at the 2023 SVB Securities Global Biopharma Conference
February 1, 2023
Achieve Life Sciences Announces Last Subject Dosed in Phase 3 ORCA-3 Trial of Cytisinicline for Smoking Cessation
January 8, 2023
Calls in 2023
- Achieve Life Sciences (NASDAQ:ACHV) Q3 2023 Earnings Call
Nov 9, 2023
Transcript - Achieve Life Sciences (NASDAQ:ACHV) Q2 2023 Earnings Call
Aug 15, 2023
Transcript - Achieve Life Sciences (NASDAQ:ACHV) Q1 2023 Earnings Call
May 9, 2023
Transcript - Achieve Life Sciences (NASDAQ:ACHV) Q4 2022 Earnings Call
Mar 16, 2023
Transcript
Decks in 2023
- Technical Presentation (May 2023)
Technical · 24 slides · May 23, 2023